Amicus Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Amicus Therapeutics, Inc. Website Screenshot

http://www.amicusrx.com

Amicus Therapeutics, Inc. Company Intro

Amicus Therapeutics) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living with rare metabolic diseases.

Industry

Healthcare

Amicus Therapeutics, Inc. Headquaters

1 Cedar Brook Drive
Cranbury,08512
United States


Amicus Therapeutics, Inc. Share price

27 Oct 2020 01:39 GMT

$18.23

-0.25 (-1.35 %)


Amicus Therapeutics, Inc. Market cap

$4.852 B


WMC RANKING

2020

Amicus Therapeutics, Inc. # 31

Biotechnology



Latest Amicus Therapeutics, Inc. News

News 26 Oct 2020

Leukodystrophy Drug Market Expected to Witness High ...

... Company Limited, CHIESI Farmaceutici S.p.A, Orchard Therapeutics plc, ... Ltd, Sangamo Therapeutics, Amicus Therapeutics, Inc, Nextrials, Inc, Protalix ...

News 26 Oct 2020

It may be game changer for your Portfolio: GlaxoSmithKline plc (GSK), Amicus Therapeutics Inc. (FOLD)

Amicus Therapeutics Inc. (FOLD) shares on Friday's trading session, jumped 2.55 percent to see the stock exchange hands at $18.48 per unit. Lets a quick look ...

News 27 Oct 2020

Lysosomal Storage Diseases Therapeutics Market Demand 2020- Size, Share, Key Trends, Wireless Technology, Comprehensive Analysis, Healthcare Infrastructure, Business Opportunities, Challenges and Highest Growth Rate During Forecast Period

... Pfizer, Inc., Sanofi, BioMarin Pharmaceutical Inc., Actelion Ltd., Raptor Pharmaceutical Corp., Protalix Biotherapeutics Inc., and Amicus Therapeutics, Inc.

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Amicus Therapeutics, Inc. 3.29 2.41 1.44 0 0 0 2.88
Alexion Pharmaceuticals, Inc. 100 13.31 100 20 0 0 100
Vertex Pharmaceuticals Incorporated 97.58 100 4.32 26 0 0 97.51
3SBio Inc. 96.05 0 0 4 0 0 2.78
Incyte Corporation 40.27 14.26 7.19 100 0 0 90.89

Amicus Therapeutics, Inc. Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
Amicus Therapeutics, Inc. $182,237 $461,014 $-356,388 $4.852B 31
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $26.467B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $53.956B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥19.394B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.779B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Amicus Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors



Amicus Therapeutics, Inc. Post vs Top 4 Industry Competitors


Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries